Overview

Digitalis Investigation Group (DIG)

Status:
Completed
Trial end date:
1998-06-01
Target enrollment:
Participant gender:
Summary
To determine if digitalis had a beneficial, harmful, or no effect on total mortality in patients with clinical heart failure and sinus rhythm.
Phase:
Phase 3
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)